Precigen, Inc.

Pharmaceutical company · Germantown, Maryland, United States · Nasdaq: PGEN

Precigen, Inc. is a pharmaceutical company headquartered in Germantown, Maryland, United States. Its shares trade on Nasdaq under the ticker PGEN. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has reported private securities offerings to the US SEC, most recently $13 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

Precigen at a glance

Typepharmaceutical company
HeadquartersGermantown, Maryland, United States
Stock listingNasdaq: PGEN
SEC industryPharmaceutical Preparations
FDA-registered sites1
SEC CIK1356090

What does Precigen do?

Operations at its FDA-registered drug sites

AnalysisAPI manufacturing

Private fundraising reported to the SEC

26 Form D notices; the most recent reported $13 million sold (2020).

Where is Precigen located?

Headquarters: Germantown, Maryland, United States

  • Germantown, MarylandPrecigen, Inc. · FDA drug site

Frequently asked questions about Precigen

Where is Precigen headquartered?

Precigen, Inc. is headquartered in Germantown, Maryland, United States.

What does Precigen do?

Precigen, Inc. is a pharmaceutical company. Its FDA-registered drug sites are registered for analysis and API manufacturing. Its SEC industry classification is Pharmaceutical Preparations.

Is Precigen a public company?

Yes. Precigen, Inc. trades on Nasdaq under the ticker PGEN.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.